Insider · CIK 0001210238

BATE KENNETH

Reports to the SEC for 11 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001210238

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,333 sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26.6K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.1K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.7K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.1K sh	—	—	0
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−30 sh	$490.98	−$14.7K	2,627
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,931 sh	$484.78	−$936K	8,896
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−696 sh	$489.09	−$340K	3,590
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−827 sh	$486.73	−$403K	7,061
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,470 sh	—	—	0
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+5,470 sh	$9.45	+$51.7K	8,097
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−933 sh	$489.95	−$457K	2,657
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,105 sh	$280.04	+$309K	19,202
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,763 sh	$480.24	−$847K	17,439
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,069 sh	$483.41	−$1M	10,827
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,775 sh	$487.49	−$1.35M	4,286
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,284 sh	$482.41	−$619K	12,896
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,259 sh	$481.13	−$1.57M	14,180
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$303.79	+$3.04M	18,097
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,008 sh	$485.54	−$489K	7,888
2025-11-05	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,105 sh	—	—	0
2025-08-15	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,516 sh	$364.24	−$916K	7,794
2025-08-15	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2025-08-15	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−896 sh	$368.56	−$330K	2,627
2025-08-15	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,104 sh	$367.63	−$406K	3,523
2025-08-15	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−600 sh	$366.14	−$220K	4,627
2025-08-15	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$16.46	+$165K	12,627
2025-08-15	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,317 sh	$363.41	−$842K	10,310
2025-08-15	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,567 sh	$365.33	−$938K	5,227
2025-06-20	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1,290 sh	—	—	1,290
2025-06-20	MDGLMADRIGAL PHARMACEUTICALS, INC.A Award	Director	AAward	+715 sh	—	—	2,627
2025-06-11	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26.6K sh	—	—	26,550
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−238 sh	$353.83	−$84.2K	21,074
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−8,545 sh	$355.08	−$3.03M	12,529
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−100 sh	$351.01	−$35.1K	21,812
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−500 sh	$351.99	−$176K	21,312
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,791 sh	$356.51	−$995K	9,738
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,530 sh	$9.45	+$42.8K	21,912
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,038 sh	$357.27	−$728K	7,700
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$111.06	+$666K	7,912
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−216 sh	$360.07	−$77.8K	1,912
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	0
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,548 sh	$358.33	−$1.27M	4,152
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,024 sh	$359.21	−$727K	2,128
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,470 sh	—	—	0
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+9,470 sh	$65.06	+$616K	17,382
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,530 sh	—	—	5,470
2024-06-25	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1,105 sh	—	—	1,105
2024-06-25	MDGLMADRIGAL PHARMACEUTICALS, INC.A Award	Director	AAward	+714 sh	—	—	1,912

Recent filings

Accepted (ET)
Jan 234
BATE KENNETH0000905148-26-000312
SEC(opens sec.gov)
Nov 74
BATE KENNETH0001628280-25-050668
SEC(opens sec.gov)

Companies

Address

C/O ASTRIA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 10TH FLOOR

BOSTON, MA, 02210